StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report sent to investors on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Performance
Shares of AEZS stock opened at $5.72 on Thursday. Aeterna Zentaris has a one year low of $3.96 and a one year high of $12.00. The company’s 50-day moving average is $5.42 and its 200 day moving average is $6.90. The company has a market capitalization of $10.26 million, a price-to-earnings ratio of -0.27 and a beta of 1.55.
About Aeterna Zentaris
Recommended Stories
- Five stocks we like better than Aeterna Zentaris
- Utilities Stocks Explained – How and Why to Invest in Utilities
- GE Vernova’s Rally Could Continue as Wind Business Gains Ground
- What is the S&P/TSX Index?
- DraftKings vs. DoubleDown: Growth in the Online Gambling Boom
- Profitably Trade Stocks at 52-Week Highs
- Join UiPath’s AI Surge and Catch the Coming Stock Price Reversal
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.